09:09 AM EST, 02/24/2025 (MT Newswires) -- Crinetics Pharmaceuticals ( CRNX ) said Monday it has named Tobin Schilke its chief financial officer, effective Friday.
Schilke was previously the CFO of Revance Therapeutics, the company said.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.